Phenomic AI develops a ground-breaking phenotypic drug discovery platform that accelerates assay development and automates the interpretation of high-content image-based screening data.
This solves the problem of challenging assay development and complex data analysis workflows that hamper cell-based phenotypic screening technology’s potential for early drug discovery.
Phenomic AI wants to improve patient outcomes with new medicines against the tumor stroma, a barrier that surrounds cancer and stops current medicines working.
It will use AI/ML to reveal drug targets that emerge from cell to cell interactions and drive novel antibody drug discovery for many diseases.
The company has worked with several early adopters of its platform and has set up an internal drug discovery program.
website: https://phenomic.ai/